Mrv1909 05201914352D 21 23 0 0 1 0 999 V2000 0.4210 3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1355 3.3000 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 1.8500 3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 3.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 2.4750 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.8500 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1355 2.4750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.4210 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.4210 1.2375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.2934 2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.0079 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 2.0625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9934 0.8250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.9934 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.2789 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5645 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7798 1.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2949 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7798 -0.2549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 1 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 5 4 1 0 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 2 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 2 0 0 0 0 8 10 1 0 0 0 0 10 11 2 0 0 0 0 5 12 1 1 0 0 0 12 13 1 0 0 0 0 13 14 2 0 0 0 0 14 15 1 0 0 0 0 15 16 2 0 0 0 0 16 17 1 0 0 0 0 17 18 2 0 0 0 0 13 18 1 0 0 0 0 18 19 1 0 0 0 0 19 20 2 0 0 0 0 20 21 1 0 0 0 0 17 21 1 0 0 0 0 M END > DB14924 > drugbank > C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2 > InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1 > CBRJPFGIXUFMTM-WDEREUQCSA-N > C15H19N5O > 285.351 > 285.158960252 > 4 > 40 > 29.9548391432101 > 1 > 2 > 0 > 1 > 1-[(2S,5R)-2-methyl-5-({7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)piperidin-1-yl]prop-2-en-1-one > 1.80 > 1.4671665896666661 > -2.80 > 0 > 3 > 1 > 19.941522115121337 > 13.589488740920235 > 6.59698849780837 > 73.91 > 82.8367 > 3 > 1 > 4.57e-01 g/l > (2R)-14-fluoro-2-methyl-6,9,10,19-tetraazapentacyclo[14.2.1.0^{2,6}.0^{8,18}.0^{12,17}]nonadeca-1(18),8,12(17),13,15-pentaen-11-one > 0 > DB14924 > approved; investigational > Ritlecitinib > 2-propen-1-one, 1-((2S,5R)-2-methyl-5-(7H-pyrrolo(2,3-D)pyrimidin-4-ylamino)-1-piperidinyl)- > Litfulo > Litfulo > Ritlecitinib tosylate $$$$